SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the March 2025 quarter is pegged at Rs. 1449.04 millions, about 7.15% up against Rs. 1352.33 millions recorded during the year-ago period.The Net Profit of the company reported a remarkable increase of 583.53% to Rs. 2565.99  millions  from Rs. 375.40 millions in previous same quarter.The Operating Profit of the company witnessed a decrease to 57.62 millions from 607.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1449.04 1352.33 7.15 5152.34 5022.48 2.59 5152.34 5022.48 2.59
Other Income 86.50 460.12 -81.20 476.17 532.46 -10.57 476.17 532.46 -10.57
PBIDT 57.62 607.00 -90.51 706.01 1020.99 -30.85 706.01 1020.99 -30.85
Interest 101.75 144.29 -29.48 391.58 629.36 -37.78 391.58 629.36 -37.78
PBDT 2682.27 466.47 475.01 3114.08 435.71 614.71 3114.08 435.71 614.71
Depreciation 71.72 68.75 4.32 235.02 271.07 -13.30 235.02 271.07 -13.30
PBT 2610.55 397.72 556.38 2879.06 164.64 1648.70 2879.06 164.64 1648.70
TAX 44.56 22.32 99.64 44.56 22.32 99.64 44.56 22.32 99.64
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2565.99 375.40 583.53 2834.50 142.32 1891.64 2834.50 142.32 1891.64
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 3.98 44.89 -91.14 13.70 20.33 -32.59 13.70 20.33 -32.59

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1838.25
Dr. Reddys Lab 1308.00
Cipla 1370.45
Zydus Lifesciences 941.25
Lupin 2475.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×